Deliver Your News to the World

Progenitor Cell Therapy Continues Expansion


Cell Therapy Manufacturing Capacity Increased in Mountain View, California.

HACKENSACK, New Jersey-(June 26, 2006)- Progenitor Cell Therapy, LLC (PCT), a leading full service provider for the contract development of cell therapies, announced today that it has completed construction of additional Class 10,000 clean room space at its manufacturing facility in Mountain View, California.
“In the past three months, we designed and constructed additional new Class 10,000 clean rooms to meet the growing demand for PCT’s cell therapy contract manufacturing services”, said Stewart Craig Ph.D., PCT’s Chief Technology Officer and Vice President. “We are now qualifying this space and are pleased to be completing our second phase of expansion after finishing the first phase in late 2005. Over the past nine months, we have increased the clean room manufacturing capacity of this facility by approximately 80% and are already in the design phase for a further doubling of our clean room space, product development capacity, and associated support areas”.
Given the rapidly expanding sector of cellular therapy and global lack of manufacturing capacity for such products, it is expected the company’s expansion strategy for both its West (California), and East (New Jersey) coast facilities will further enhance PCT’s position as the leading contract development company for the cell therapy industry.
“We continue to strategically position our core business to meet the demands of the maturing cell therapy industry. Our success is built on the interactive partnering approach we take with clients to provide them with customized solutions that meet their development and manufacturing needs. With a world-recognized team of experts in the field, PCT can offer clients rapid responses and solutions to their specific needs” said Robert A. Preti Ph.D., President and Chief Scientific Officer of PCT.
Specializing in the provision of contract consulting, development and manufacturing services for cell-based therapeutics, PCT supports its clients at all stages of product development, from concept through clinical trials and on to commercialization.

About Progenitor Cell Therapy, LLC
Progenitor Cell Therapy is a client-based cell therapy services company that supports the development of cellular therapies by providing cGMP-compliant cell manufacturing and consulting services that address regulatory, financial, technical, process, and quality system strategies. PCT provides a full spectrum of support including process and product development, consulting, validation, due diligence evaluations, tissue collection, processing, and storage, product manufacturing, distribution and transportation. For more information, visit


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.